IP Verse

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions - EP1968630

The patent EP1968630 was granted to Boehringer Ingelheim Animal Health USA on Jan 24, 2018. The application was originally filed on Dec 28, 2006 under application number EP06848471A. The patent is currently recorded with a legal status of "Revoked".

EP1968630

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP06848471A
Filing Date
Dec 28, 2006
Status
Revoked
Jul 17, 2024
Grant Date
Jan 24, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LABORATORIOS HIPRAOct 24, 2018GRUNECKER PATENTADMISSIBLE
ELANCOOct 23, 2018POTTER CLARKSONADMISSIBLE
INTERVETOct 23, 2018INTERVETWITHDRAWN

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2004132178
INTERNATIONAL-SEARCH-REPORTUS6391314
OPPOSITIONAU2003248395
OPPOSITIONEP1926496
OPPOSITIONGB2282811
OPPOSITIONUS2002146432
OPPOSITIONUS2003170270
OPPOSITIONUS6703023
OPPOSITIONUS7122192
OPPOSITIONUS75501505P
OPPOSITIONWO0001409
OPPOSITIONWO2005009462
OPPOSITIONWO2006072065
OPPOSITIONWO2007076520
OPPOSITIONWO9307898
OPPOSITIONWO9418311
SEARCHWO2005009462
SEARCHWO2006072065

Non-Patent Literature (NPL) Citations (49) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- CARILLO, H.; LIPMAN, D., S1AM J. APPLIED MATH., (1988), vol. 48, page 1073
DESCRIPTION- DEVEREUX,J. ET AL., NUCLEIC ACIDS RESEARCH
OPPOSITION- Anonymous, "The first FLEX Familyâ„¢ vaccine for PCV2 protection in a single injection", Boehringer
OPPOSITION- Baculovirus Expression Vector System Manual
OPPOSITION- BOGA et al., "A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection", J Gen Virol, (19970000), vol. 78, no. 9, pages 2315 - 2318, XP002450362
OPPOSITION- C. CHARREYRE et al., "Vaccination challenge trials with an inactivated vaccine against PRRS", Proceedings of the 15th IPVS Congress, Birmingham, (19980705), vol. 2, page 139, XP055525284
OPPOSITION- "Combination Vaccine", National Hog Farmer, (20031215), page 42
OPPOSITION- Desmettre et al., "Chapter 9 Research and Development", Desmettre et al., Pastoret et al., Veterinary Vaccinology, Elsevier, (19970000), page 175, 177, 178, XP055277388
OPPOSITION- FAN et al., "Baculovirus insect expression and immunological studies of porcin circovirus type 2 capsid protein", Proc 2nd Asian Pig Vet Soc Congress, (20050000), pages 186 - 188, XP055292703
OPPOSITION- GERDTS et al., "Fetal immunization by DNA vaccine delivered into the oral cavity", Nature Medicine, (20000000), vol. 6, pages 929 - 932, XP055516967
OPPOSITION- GERDTS et al., "Oral DNA Vaccination In Utero Induces Mucosal Immunity and Immune Memory in the Neonate", J Immunol, (20020000), vol. 168, pages 1877 - 1885, XP055516960
OPPOSITION- HAAKE et al., "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Veterinary Microbiology, (20130000), pages 1 - 9, XP055502963
OPPOSITION- HAAKE et al., "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Vet. Microbiol., (20130000), pages 1 - 9, XP055502963
OPPOSITION- HOOGLAND et al., "Effects of adjuvants on porcine circovirus type 2-associated lesions", J. Swine Health and Production, (20060000), vol. 14, no. 3, pages 133 - 139, XP055031472
OPPOSITION- "Ingelvac CircoFLEX", European Medicines Agency, (20171110), XP055487829
OPPOSITION- JEONG et al., "Comparative efficacy of concurrent administration of a porcine circovirus type 2 (PCV2) vaccine plus a porcine reproductive and respiratory syndrome virus (PRRSV) vaccine from two commercial sources in pigs challenged with both viruses", J. Swine Health and Production, (20160000), vol. 24, pages 130 - 141, XP055525287
OPPOSITION- Mengeling et al., "The porcine reproductive and respiratory syndrome quandary. Part II: Vaccines and vaccination strategy", Journal of Swine Health and Production, (20050500), pages 152 - 156, XP055524945
OPPOSITION- NAWAGITGUL et al., "Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein", J Gen Virol, (20000000), vol. 81, no. 9, pages 2281 - 2287, XP002978778
OPPOSITION- REYNAUD et al., "SAFETY OF A HIGH DOSE ADMINISTRATION OF AN INACTIVATED ADJUVANTED PCV2 VACCINE IN CONVENTIONAL GILTS", Proceedings of the 18th IPVS Congress, vol. 1, (20040000), page 87, URL: https://www.aasv.org/library/swineinfo/Content/IPVS/2004/709.pdf, XP055516942
OPPOSITION- ROOF et al., "Evaluation of the immune response and efficacy of 1 and 2 dose commercial Mycoplasma hyopneumoniae bacterins", American Association of Swine Veterinarians, (20010000), pages 163 - 167, XP055516930
OPPOSITION- SALMON, "Immunité chez le foetus et le nouveau-né: modèle porcin", Reprod Nutr Développement, (19840000), vol. 24, pages 197 - 206, XP055516981
OPPOSITION- SCHINKEL et al., "Analysis of Pig Growth from Birth to Sixty Days of Age", Swine Research Report. Purdue University, (20030000), pages 57 - 67, XP055277371
OPPOSITION- TRUCHAN et al., "Eighteen Week Duration of Immunity in Pigs Vaccinated at 3 or 8 Weeks of Age with One Dose of a Mycoplasma hyopneumoniae Bacterin", American Association of Swine Practitioners, (20000000), page 125, XP002734481
OPPOSITION- URNIZA et al., "Abstract No: P.07-09 DURATION OF IMMUNITY STUDY IN PIGS VACCINATED WITH AN INACTIVATED/ADJUV ANTED VACCINE 'CHIMERIC PORCINE CIRCOVIRUS TYPE 1/TYPE 2' IN FRONT OF A CHALLENGE WITH PCV2 EUROPEAN STRAIN", Proceedings of the 19th IPVS Congress, Copenhagen, (20060000), vol. 2, page 108, XP055446549
OPPOSITION- WEINGARTL, "Porcine circovirus structure and replication a minireview", Agricultura, (20020000), vol. 1, pages 11 - 14, XP055292683
OPPOSITION- WEINGARTL, "Porcine circovirus structure and replication a minireview", Agriculture, (20020000), vol. 1, pages 11 - 14, XP055292683
OPPOSITION- ALLAN et al., "EXPERIMENTAL INFECTION OF COLOSTRUM DEPRIVED PIGLETS WITH PORCINE CIRCOVIRUS 2 (PCV2) AND PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) POTENTIATES PCV2 REPLICATION", Archive Virology, (20000000), vol. 145, pages 2421 - 2429, XP001020811
OPPOSITION- NIELSEN et al., "Experimental in utero infection of pig foetuses with porcine parvovirus (PPV).", Vet Microbiol, (19910000), vol. 28, no. 1, pages 1 - 11, XP024342399
OPPOSITION- SALMON et al., "Humoral and cellular factors of maternal immunity in swine", Dev Comp Immunol, (20090000), vol. 33, no. 3, pages 384 - 393, XP025762043
OPPOSITION- ALEXOPOULOS et al., "Sow performance in an endemically porcine reproductive and respiratory syndrome (PRRS)-infected farm after sow vaccination with an attenuated PRRS vaccine", Veterinary Microbiology, (20050000), vol. 111, pages 151 - 157, XP005180367
OPPOSITION- BACHMANN et al., "The influence of virus structure on antibody responses and virus serotype formation", Immunology Today, (19960000), vol. 17, no. 12, pages 553 - 558, XP004071007
OPPOSITION- LILJEQVIST et al., "Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines", J. Biotechnol., (19990730), vol. 73, pages 1 - 33, XP004180163
OPPOSITION- MORAES et al., "Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24", Vaccine, (20020000), vol. 20, pages 1631 - 1639, XP004340386
OPPOSITION- BLANCHARD et al., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, (20030000), vol. 21, no. 31, pages 4565 - 4575, XP004467337
OPPOSITION- BLANCHARD et al., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, (20030000), vol. 21, pages 4565 - 4575, XP004467337
OPPOSITION- BLANCHARD et al., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, (20031107), vol. 21, no. 31, pages 4565 - 4575, XP004467337
OPPOSITION- NOAD et al., "Virus-like particles as immunogens", TRENDS in Microbiology, (20030000), vol. 11, pages 438 - 444, XP003004438
OPPOSITION- OPRIESSNIG et al., "Comparison of Molecular and Biological Characteristics of a Modified Live Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Vaccine (Ingelvac PRRS MLV), the Parent Strain of the Vaccine (ATCC VR2332), ATCC VR2385, and Two Recent Field Isolates of PRRSV", J. Virol., (20020000), vol. 76, pages 11837 - 11844, XP002997173
OPPOSITION- ROVIRA et al., "Experimental Inoculation of Conventional Pigs with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus 2", Journal of Virology, (20020000), vol. 76, no. 7, pages 3232 - 3239, XP055527104
OPPOSITION- FENAUX et al., "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", Journal of Virology, (20040000), vol. 78, no. 12, pages 6297 - 6303, XP008039321
OPPOSITION- FENAUX et al., "A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Cloned into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in Pigs", J. Virol., (20040000), vol. 78, no. 12, pages 6297 - 6303, XP008039321
OPPOSITION- DAWSON et al., "Studies of the field efficacy and safety of a single-dose Mycoplasma hyopneumoniae vaccine for pigs", Vet Rec, (20020000), vol. 151, pages 535 - 538, XP008048796
OPPOSITION- KRAKOWKA et al., "Activation of the Immune System is the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2)", Vet Pathol, (20010000), vol. 38, no. 1, pages 31 - 42, XP055277395
OPPOSITION- BOISGERAULT et al., "Virus-like particles: a new family of delivery systems", Expert Review of Vaccines, (20020000), vol. 1, no. 1, pages 101 - 109, XP008099122
SEARCH[ ] - BOEHRINGER INGELHEIM, "Ingelvac CircoFLEX-MycoFLEX Combo pack receives APHIS approval.", PRESS RELEASE, 12 AUGUST 2008, URL: http://flexcombo.com/documents/CircoFLEX-MycoFLEX-APHIS-Approval.pdf [ ] * the whole document *
SEARCH[ ] - BOEHRINGER INGELHEIM, "Ingelvac MycoFLEX", MATERIAL SAFETY DATA SHEET (14-08-2008), URL: http://www.bimsds.us/msds/Ingelvac_MycoFLEX_msds.pdf [ ] * the whole document *
SEARCH- BOEHRINGER INGELHEIM VETMEDICA, "Data from studies consistent with maintaining safety and efficacy of Ingelvac CircoFLEX and Ingelvac MycoFLEX vaccines when mixed toghether and administered concurrently in pigs.", TECHNICAL BULLETIN, FEBRUARY 2008, URL: http://www.bi-vetmedica.com/swine-research/MycoFLEX-Mycoplasma-immunity_TB2.pdf, XP002503389 [T] * the whole document *
SEARCH- BLANCHARD P ET AL, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20031107), vol. 21, no. 31, ISSN 0264-410X, pages 4565 - 4575, XP004467337 [Y] 1-20,25 * the whole document *
SEARCH- BLANCHARD PH ET AL, "An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome", VETERINARY MICROBIOLOGY,, (20030717), vol. 94, no. 3, pages 183 - 194, XP002502413 [A] 1,11 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents